CSL signs enterprise agreement with BrightInsight following success of Hizentra app
CSL Behring leveraged the BrightInsight Platform® to launch a mobile app for adult patients with rare diseases who are taking Hizentra.Read Now
"After conducting a rigorous evaluation, we selected BrightInsight because it has the only regulated solution with a robust Quality Management System and comprehensive privacy and security certifications. BrightInsight’s Platform allows us to focus on therapeutic innovation, rather than the underlying digital technology."
– Brian Johnson, Senior Director, Customer Engagement Management at CSL BehringLearn More
"We have found in BrightInsight a partner who shares our commitment to advancing public health with innovative, customer-centric solutions. Our engagement with BrightInsight will enable us to bring our digital health solutions to market faster with the goal of improving patient outcomes."
– Brian Armstrong, Senior Vice President, Clinical Operations – North America, bioMérieuxLearn More
"Digital enables more engaging patient experiences by increasing therapy compliance, improving disease and medical tracking and, as importantly, building connections among patients and with healthcare providers. The data collected with digital can be used to deliver more personalized therapies, increase reimbursement and potentially increase revenues through extended patent life."
– Brad Gescheider, Global Head, Digital Innovation and Patient Services, Immunology at SanofiLearn More
"If you leverage a solution like BrightInsight that meets the most stringent requirements and maintains compliance as part of their managed service, you don’t have to worry about your regulated digital solutions in the U.S. versus Europe versus U.K. and so on. You just know they’re compliant."
– Paul Upham, Head of Smart Devices, Roche/GenentechLearn More
"Medical-grade digital health platforms like BrightInsight are key to helping us improve the conversation between people with diabetes and their caregivers."
– Anders Dyhr Toft, former Corporate Vice President, Commercial Innovation, Novo NordiskLearn More
countries are deployment ready
of combined forecast for peak annual sales for drugs and IVD assets on our platform
disease states covered
Software as a Medical Device disease management solution for one of Sanofi’s most important treatments
BrightInsight provides a unified IoT platform that enables Novo Nordisk to develop and host digital health devices, apps and algorithms.